BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12669120)

  • 1. Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases.
    Sase T; Wada H; Nishioka J; Abe Y; Gabazza EC; Shiku H; Suzuki K; Nakamura S; Nobori T
    Thromb Haemost; 2003 Apr; 89(4):660-5. PubMed ID: 12669120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor messenger RNA levels in leukocytes compared with tissue factor antigens in plasma from patients in hypercoagulable state caused by various diseases.
    Sase T; Wada H; Kamikura Y; Kaneko T; Abe Y; Nishioka J; Nobori T; Shiku H
    Thromb Haemost; 2004 Jul; 92(1):132-9. PubMed ID: 15213854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of leukocyte tissue factor mRNA in patients with venous thromboembolism.
    Kamikura Y; Wada H; Nobori T; Kobayashi T; Sase T; Nishikawa M; Ishikura K; Yamada N; Abe Y; Nishioka J; Nakano T; Shiku H
    Thromb Res; 2005; 116(4):307-12. PubMed ID: 16038715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
    Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus type 1-encoded glycoprotein C enhances coagulation factor VIIa activity on the virus.
    Sutherland MR; Friedman HM; Pryzdial EL
    Thromb Haemost; 2004 Nov; 92(5):947-55. PubMed ID: 15543320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid in vivo induction of leukocyte tissue factor mRNA and protein synthesis following low dose endotoxin administration to rabbits.
    Brutzki TC; Kulczycky MJ; Bardossy L; Clarke BJ; Blajchman MA
    Hematol J; 2001; 2(3):188-95. PubMed ID: 11920244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
    Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
    Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic abnormalities and leukocyte activation caused by infection in patients with malignant lymphoma during chemotherapy.
    Kamikura Y; Wada H; Sase T; Yamaguchi M; Kaneko T; Sakaguchi A; Abe Y; Nishioka J; Nobori T; Shiku H
    Thromb Res; 2006; 117(6):671-9. PubMed ID: 16026816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
    Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Am J Hematol; 1997 Aug; 55(4):169-74. PubMed ID: 9257875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma level of stromal derived factor-1 (SDF-1) is increased in disseminated intravascular coagulation patients who have poor outcomes: in vitro effect of SDF-1 on coagulopathy.
    Kim HK; Kim JE; Chung J; Lee DS; Han KS; Park S; Cho HI
    Thromb Res; 2007; 120(4):559-66. PubMed ID: 17239427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation.
    Wada H; Nakase T; Nakaya R; Minamikawa K; Wakita Y; Kaneko T; Ohiwa M; Deguchi K; Shirakawa S
    Am J Hematol; 1994 Mar; 45(3):232-6. PubMed ID: 8296794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa.
    Aberg M; Wickström M; Siegbahn A
    Thromb Res; 2008; 122(2):191-202. PubMed ID: 18031796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of leukocyte receptors in disseminated intravascular coagulation: prognostic value of low protein C receptor expression.
    Sung JY; Kim JE; Kim KS; Han KS; Kim HK
    Thromb Res; 2014 Nov; 134(5):1130-4. PubMed ID: 25246042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tissue factor and tissue factor pathway inhibitor in rats lungs with lipopolysaccharide-induced disseminated intravascular coagulation.
    Hara S; Asada Y; Hatakeyama K; Marutsuka K; Sato Y; Kisanuki A; Sumiyoshi A
    Lab Invest; 1997 Dec; 77(6):581-9. PubMed ID: 9426395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased thrombomodulin mRNA expression on peripheral monocytes in disseminated intravascular coagulation patients relates to poor outcomes: the ex vivo effects of lipopolysaccharide and thrombin on monocyte thrombomodulin and CD14 mRNA.
    Hong SK; Kim JE; Han KS; Kim HK
    Thromb Res; 2013 Sep; 132(3):392-7. PubMed ID: 23954259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
    Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of factor Xa suppresses the expression of tissue factor in human monocytes and lipopolysaccharide-induced endotoxemia in rats.
    Akahane K; Okamoto K; Kikuchi M; Todoroki H; Higure A; Ohuchida T; Kitahara K; Takeda S; Itoh H; Ohsato K
    Surgery; 2001 Nov; 130(5):809-18. PubMed ID: 11685190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism in the tissue factor region is associated with basal but not endotoxin-induced tissue factor-mRNA levels in leukocytes.
    Marsik C; Endler G; Halama T; Schlifke I; Mustafa S; Hysjulien JL; Key NS; Jilma B
    J Thromb Haemost; 2006 Apr; 4(4):745-9. PubMed ID: 16634740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant expression of tissue factor antigen and procoagulant activity on human monocytes activated with LPS and low dose cycloheximide.
    Walsh JD; Geczy CL
    Thromb Haemost; 1991 Nov; 66(5):552-8. PubMed ID: 1803619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.